Hualan Biological Engineering Inc. (SHE:002007)
China flag China · Delayed Price · Currency is CNY
11.73
+0.05 (0.43%)
Nov 17, 2026, 3:04 PM CST

SHE:002007 Revenue

Hualan Biological Engineering had revenue of 1.02B CNY in the quarter ending September 30, 2026, a decrease of -35.75%. This brings the company's total for the last twelve months to 3.80B, down -10.99% year-over-year. In the year 2025, Hualan Biological Engineering had annual revenue of 4.60B with 4.93% growth. That makes Hualan Biological Engineering the 10,549th largest company in the world by revenue and 1,735th in China.

Revenue (ttm)
3.80B
Revenue Growth
-10.99%
P/S Ratio
5.71
Revenue / Employee
922.59K
Employees
4,117
Market Cap
21.42B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Blood Product 3.39B 73.7%
  • Vaccine Product 1.20B 26.0%
  • Others 12.88M 0.3%

By Geography

Chart
  • China 4.59B 100.0%
  • Overseas 2.27M 0.0%
Fiscal year ended Dec 31, 2025 See the full SHE:002007 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.60B215.82M4.93%
Dec 31, 20244.38B-962.68M-18.02%
Dec 31, 20235.34B824.89M18.26%
Jan 1, 20234.52B80.78M1.82%
Jan 1, 20224.44B-587.01M-11.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.